
Gene therapy has the potential to improve the clinical outcome of many zzso by transferring therapeutic genes into tumor cells or normal host zzso Gene transfer into tumor cells or zzso zzso is being employed to induce tumor cell death, stimulate zzso immune response, inhibit zzso and control tumor cell zzso zzso zzso have been used to achieve this proof of principle in animal models and, in select cases, in human clinical zzso Nevertheless, there has been considerable interest in developing zzso zzso for cancer gene zzso zzso zzso are zzso more amenable to large-scale zzso and potentially safer for clinical zzso zzso zzso were once limited by low gene transfer efficiency and transient or steadily declining gene zzso However, recent improvements in zzso zzso and delivery methods are showing promise in zzso these zzso This article reviews the current status of zzso cancer gene therapy, with an emphasis on combination strategies, long-term gene transfer using zzso and zzso zzso and future zzso 

